FIRST LOCALIZED HYPERTHERMIA & IMAGING SOLUTION TECHNOLOGIES IN MAGNETIC PARTICLE IMAGING
Introducing HYPER, the first localized and non-invasive deep tissue RF hyperthermia technology offering spatial control of heating to millimeter-scales, and real-time monitoring of therapeutic heat for ablation, drug release, and cell activation models.
With the addition of the HYPER module, researchers can identify, target and treat in combination with the MOMENTUM Magnetic Particle Imaging System. MPI is a non-invasive imaging technology that directly detects and quantitates magnetic tracers with exceptional contrast and sensitivity. Magnetic tracers, such as iron oxide, have been used clinically for many years. MPI harnesses these and similar tracers with the ability to both image tumors, cell trafficking, and vascular perfusion, and locally induce heat, which can direct therapeutic payloads or directly ablate disease sites with millimeter accuracy. More information here
Tracer Optimization and Development Relaxometry Toolkit for the MOMENTUM Magnetic Particle Imaging System
Screen and optimize your nanoparticle directly on the MOMENTUM™ Magnetic Particle Imaging System with the RELAX particle relaxometry toolkit.
The flexibility and breadth of applications are highly dependent on your choice of nanoparticle. Performance can vary widely and influences image quality, sensitivity and resolution. Get the most out of your tracer by using RELAX for your specific application. More information here
MPI IN IMMUNO-ONCOLOGY
The success of cancer immunotherapy has driven the rapid growth of research into immuno-oncology, which has, in turn, fueled the need to be able to determine the location of a variety of immune cells in solid tumors systemically over time. However, existing methods to track immune cells systemically have been insufficient. Magnetic particle imaging (MPI) can be used to non-invasively track immune cells in vivo. By combining accurate quantification and specificity, MPI can provide information on macrophage and other immune cell distribution over time.
